Telomir Pharmaceuticals Inc. Common Stock

TELO | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.25

+$0.01 (+0.81%)

Sep 22, 2026, 1:09 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-4.32M	-9.39M	-10.54M	-11.31M	-16.17M	-12.57M	-12.3M	-10.48M	-5.42M	-5.38M	-3.94M	-3.35M	-2.63M	-1.27M	-854.15K	-367.05K	-133.55K	-63.49K
Interest Income	214.15K	169.34K	117.69K	52.65K	23.87K	48K	48K	40.94K	25.49K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-51.99M	-9.22M	-10.41M	-11.25M	-16.14M	-12.52M	-16.59M	-23.02M	-18.74M	-18.84M	-13.07M	-4.23M	-2.75M	-1.27M	-854.15K	-367.05K	-133.55K	-63.49K
Net Income	-51.99M	-9.22M	-10.41M	-11.25M	-16.14M	-12.52M	-16.59M	-23.02M	-18.74M	-18.84M	-13.07M	-4.23M	-2.75M	-1.27M	-854.15K	-367.05K	-133.55K	-63.49K
Selling & General & Admin	3.12M	6.83M	8.1M	9.9M	14.89M	10.75M	9.64M	7.4M	2.71M	1.89M	1.19M	804.09K	116.25K	59.89K	20.94K	11.15K	7.4K	3.65K
Research & Development	2.97M	2.57M	2.44M	1.41M	1.28M	1.83M	2.3M	2.23M	1.87M	1.94M	1.57M	1.85M	1.82M	1.21M	833.21K	355.9K	126.15K	59.84K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	370.5K	850.05K	850.05K	1.55M	1.18M	698.6K	698.6K	0	0	n/a	n/a	n/a
Operating Expenses	6.09M	9.39M	10.54M	11.31M	16.17M	12.57M	12.3M	10.48M	5.42M	5.38M	3.94M	3.35M	2.63M	1.27M	854.15K	367.05K	133.55K	63.49K
Interest Expense	957	5.33K	4.07K	4.07K	1.34K	n/a	4.34M	5.1M	5.86M	5.98M	1.64M	881.23K	124.05K	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	589.4K	589.4K	589.4K	589.4K	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	4.32M	9.39M	10.54M	11.31M	16.17M	12.57M	12.3M	10.48M	5.42M	5.38M	3.94M	3.35M	2.63M	1.27M	854.15K	367.05K	133.55K	63.49K
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	60.84M	34.38M	34.38M	31.04M	30.01M	29.76M	29.54M	29.61M	29.61M	29.28M	29.61M	29.61M	29.61M	29.61M	29.61M	29.61M	29.61M	29.61M
Shares Outstanding (Diluted)	60.84M	34.38M	34.38M	31.04M	30.01M	29.76M	29.54M	29.61M	29.61M	29.28M	29.61M	29.61M	29.61M	29.61M	29.61M	29.61M	29.61M	29.61M
EPS (Basic)	-0.91	-0.29	-0.34	-0.38	-0.54	-0.42	-0.58	-0.80	-0.66	-0.66	-0.45	-0.14	-0.09	-0.04	-0.03	-0.01	0	0
EPS (Diluted)	-0.91	-0.29	-0.34	-0.38	-0.54	-0.42	-0.58	-0.80	-0.66	-0.66	-0.45	-0.14	-0.09	-0.04	-0.03	-0.01	0	0
EBITDA	-4.15M	-9.22M	-10.41M	-11.25M	-16.14M	-12.49M	-10.31M	-15.98M	-10.94M	-10.95M	-10.95M	-2.38M	-1.66M	-233.5K	-296.99K	-296.99K	-63.49K	-63.49K
EBIT	-4.15M	-9.22M	-10.41M	-11.25M	-16.14M	-12.52M	-12.25M	-17.92M	-12.88M	-12.86M	-11.43M	-3.35M	-2.63M	-1.27M	-854.15K	-367.05K	-133.55K	-63.49K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	25.49K	1.94M	1.94M	1.94M	1.92M	482.94K	970.03K	970.03K	1.04M	557.16K	70.06K	70.06K	n/a